First heterobimetallic Cu(i)-dppf complexes designed for anticancer applications: Synthesis, structural characterization and cytotoxicity

Keyphrases

• 1,1'-bis(diphenylphosphino)ferrocene 16%
• 1,10-Phenanthroline 16%
• 2,4,6-tri(2-pyridyl)-1,3,5-triazine 16%
• 2-(2-pyridyl)benzimidazole 16%
• Amines 16%
• Analytical Method 16%
• Anticancer Drugs 16%
• Application Synthesis 100%
• Bidentate Ligands 16%
• Cisplatin 16%
• Cytotoxicity 100%
• Dppf 100%
• Electrochemical Techniques 16%
• Fibroblasts 16%
• Heteroaromatics 16%
• Heterobimetallic 100%
• Human Breast Adenocarcinoma Cells 16%
• Human Breast Cancer Cells 16%
• IC50 Value 33%
• MCF-7 16%
• Order of Magnitude 16%
• Single Crystal Structure 16%
• Spectroscopic Techniques 16%
• Structural Characterization 100%
• Tumoral Cells 16%
• X-ray Diffraction Study 16%

Chemistry

• 1,2,4-triazine 50%
• Antineoplastic Agent 50%
• Benzimidazole 50%
• Biphenyl 50%
• Cisplatin 50%
• Crystal Structure 50%
• Ferrocene 50%
• IC50 100%
• Single Crystalline Solid 50%
• X-Ray Diffraction 50%